MedTrace Logo

Telemedical Interventional Monitoring in Heart Failure

NCT00543881 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 710

Last updated 2016-12-21

No results posted yet for this study

Summary

Superiority of additional Remote Patient Monitoring in patients with CHF In comparison to usual care in terms of:

* reduction of mortality rate
* reduction of hospitalizations
* increasement of patients' quality of life

Conditions

Interventions

DEVICE

Remote patient monitoring (Partnership for the Heart)

Guideline-based care in heart failure (NYHA II-III) including at least 5 scheduled doctor's visits plus daily monitoring of ECG, weight, blood pressure, self-report of health status, weekly monitoring of physical fitness

DEVICE

Usual care group

Guideline-based care in heart failure (NYHA II-III) including at least 5 scheduled doctor's visits

Sponsors & Collaborators

  • German Federal Ministry of Economics and Technology

    collaborator OTHER_GOV

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Friedrich Koehler, MD · Charité - Universitaetsmedizin Berlin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-07-31
Completion
2010-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00543881 on ClinicalTrials.gov